Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Entero Healthcare Solutions's revenue for the
three
months ended in Jun. 2026 was ₹19,405 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ₹71,279 Mil.
Entero Healthcare Solutions's Revenue per Share for the
three
months ended in Jun. 2026 was ₹445.44.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ₹1,635.94.
During the past 6 years, Entero Healthcare Solutions's highest 3-Year average Revenue per Share Growth Rate was 38.20% per year. The lowest was 25.60% per year. And the median was 26.20% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Entero Healthcare Solutions Revenue Related Terms
Entero Healthcare Solutions Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Entero Healthcare Solutions's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Entero Healthcare Solutions Revenue vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Entero Healthcare Solutions's Revenue distribution charts can be found below:
* The bar in red indicates where Entero Healthcare Solutions's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹71,279 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Entero Healthcare Solutions (NSE:ENTERO) has a Revenue of ₹71,279 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Entero Healthcare Solutions and its competitors.
Is Entero Healthcare Solutions' Revenue too high?
Entero Healthcare Solutions' current Revenue is ₹71,279 Mil. Overall, Entero Healthcare Solutions has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Entero Healthcare Solutions' Revenue compare to MCK and COR?
Entero Healthcare Solutions' Revenue of ₹71,279 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Distribution company?
A good Revenue depends on the Medical Distribution industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Entero Healthcare Solutions and its competitors. Entero Healthcare Solutions's current Revenue is ₹71,279 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entero Healthcare Solutions stock overvalued right now?
Based on GuruFocus' analysis, Entero Healthcare Solutions (NSE:ENTERO) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,739.74, compared to a current price of ₹1,408.40 — trading 19% below its estimated fair value. The current Revenue is ₹71,279 Mil. Entero Healthcare Solutions' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Entero Healthcare Solutions (NSE:ENTERO), the current Revenue is ₹71,279 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Entero Healthcare Solutions (NSE:ENTERO) Overvalued in 2026?
Based on GuruFocus' analysis, Entero Healthcare Solutions stock appears to be undervalued.
The current stock price of ₹1,408.40 is trading 19% below its estimated GF Value™ of ₹1,739.74.
GuruFocus considers Entero Healthcare Solutions to be Modestly Undervalued.
Key valuation signals for NSE:ENTERO:
Revenue: ₹71,279 Mil
GF Value™: ₹1,739.74 vs. price of ₹1,408.40 (19% below fair value)
No single metric tells the full story. See the NSE:ENTERO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.
67GF Score
Get the complete analysis for NSE:ENTERO
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ENTERO has been successfully added to your 
